« Return to News | CROs/Service Providers

Icon launches risk-based monitoring service

Monday, August 26, 2013 12:12 PM

Global CRO Icon has launched ICONIK Monitoring, the first in a series of new services that will leverage its ICONIK technology platform.

ICONIK Monitoring enables the targeted use of monitoring resources by using scientific analysis of real-time data, together with CRA site knowledge, to direct central and on-site monitoring activities based on need. It uses event, data volume and risk-based triggers to ensure effective use of monitoring resources. It is designed to meet regulatory and quality requirements for GCP and is consistent with the guidance documents published by the FDA and EMA on risk-based monitoring, and with the TransCelerate Risk Based Monitoring Methodology.

Icon continuously refines the metrics selected for surveillance using ICONIK monitoring and the algorithms used to calculate those metrics. These settings and the pre-programmed methodologies for combing databases and comparing data points can be adapted to suit the study protocol and therapeutic area.

“ICONIK Monitoring enables us to rapidly identify and resolve site-related issues and achieve a higher level of process and data consistency across sites,” said Dr. Nuala Murphy, executive vice president, global clinical and data operations, Icon Clinical Research.  “By ensuring more effective use of site visits, ICONIK Monitoring can also reduce study costs and in some large studies these savings can be as high as 15% to 25% of the overall cost of the study.”

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.